Document:

emergentbiosolutions70f0

Certain identified information has been excluded from the exhibit because it is both (i) not material  and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks  denote omissions.      AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE    PAGE OF PAGES  1 3  2. AMENDMENT/MODIFICATION NO.   P0004  3.  EFFECTIVE DATE  See Block 16C  4. REQUISITION/PURCHASE REQ. NO.   OS279861  5. PROJECT NO. (If applicable)  6. ISSUED BY CODE ASPR/SNS 7. ADMINISTERED BY (If other than Item 6)    CODE ASPR/SNS  ASPR/SNS  ASPR/SNS  2945 Flowers Road  ATLANTA, GA 30341    US DEPT OF HEALTH & HUMAN SERVICES  ASPR/SNS  2945 Flowers Road  ATLANTA, GA 30341    8.  NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)  (x) 9A. AMENDMENT OF SOLICITATION NO.  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.  Attn:  Chris Sinclair  PRODUCT DEVELOPMENT GAITHE  300 PROFESSIONAL DR.  GAITHERSBURG MD 208793419      9B. DATED (SEE ITEM 11)     x 10A. MODIFICATION OF CONTRACT/ORDER NO.   75A50119C00071   10B. DATED (SEE ITEM 13)  CODE    1365869 FACILITY CODE     08/30/2019  11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS   The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers  is extended,  is not extended.  Offers  must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items  8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or   (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO  BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each  letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA (If required)     Net Increase:    $182,182,000.00  See Schedule  13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.   IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.  CHECK ONE  A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT  ORDER NO. IN ITEM 10A.     B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,  appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).    C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:    FAR Clause 52.217-9, Option to Extend the Term of the Contract (Mar 2000)    D. OTHER (Specify type of modification and authority)      E. IMPORTANT:  Contractor    is not,  is required to sign this document and return ____1____ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**]  DUNS Number: [**]  ACAM2000, Smallpox (Vaccinia) Vaccine, Live (ACAM)    Purpose of this modification is to exercise and fund Option 2, Year 3, CLIN 2004, Task 1   ACAM 2000 Vaccine; Qty: [**] X $[**] = $[**].   The Period of Performance is [**] - [**]   New Deliverables / Due Dates: [**] - [**]    Continued ...  Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print).  Adam Havey, EVP, Business Operations  16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  NATASHA Y. ROWLAND  15B. CONTRACTOR/OFFEROR    /s/ Adam Havey   (Signature of person authorized to sign)  15C. DATE  SIGNED    July 13, 2021  16B. UNITED STATES OF AMERICA  /s/ Natasha Rowland S      16C. DATE SIGNED  July 13, 2021  

 

  (Signature of Contracting Officer)   STANDARD FORM 30 (Rev. 11/2016)  Previous edition unusable Prescribed by GSA FAR (48 CFR) 53.243  

 

    CONTINUATION  SHEET  REFERENCE NO. OF DOCUMENT BEING CONTINUED  5A50119C00071/P00004   PAGE OF   2 3  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM No.  (A)  SUPPLIES/SERVICES  (B)  QUANTITY  (C)  UNIT  (D)  UNIT  PRICE  (E)  AMOUNT  (F)                                  5                                6                              Add Item 5 as follows:       Warm based manufacturing delivery for  ACAM2000   Vaccine CAN 199SN21 [**]   Obligated Amount: $[**]     Accounting Info:   2021.199SN21.26088 Appr. Yr.: 2021 CAN:  199SN21   Object Class: 26088   Funded: $[**]     Add Item 6 as follows:     Warm based manufacturing delivery for  ACAM2000   Vaccine CAN 199SN20 [**]   Obligated Amount: $[**]   Accounting Info:   2021.199SN20.26088 Appr. Yr.: 2021 CAN:  199SN20   Object Class: 26088   Continued ...                                       [**]                   [**]       NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFR) 53.110   

 

    CONTINUATION  SHEET  REFERENCE NO. OF DOCUMENT BEING CONTINUED  75A50119C00071/P00004   PAGE OF   3 3  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM No.  (A)  SUPPLIES/SERVICES  (B)  QUANTITY  (C)  UNIT  (D)  UNIT  PRICE  (E)  AMOUNT  (F)   Funded: $[**]         No further changes.                                               NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFR) 53.110   

 

    NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869                                                                                                                      NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFR) 53.110emergentbiosolutions77ea

Certain identified information has been excluded from the exhibit because it is both (i) not material  and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks  denote omissions.      AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES  1 3  2. AMENDMENT/MODIFICATION NO.   P0005  3.  EFFECTIVE DATE  See Block 16C  4. REQUISITION/PURCHASE REQ. NO.   OS2585049  5. PROJECT NO. (If applicable)  6. ISSUED BY CODE ASPR/SNS 7. ADMINISTERED BY (If other than Item 6)    CODE ASPR/SNS  ASPR/SNS  ASPR/SNS  2945 Flowers Road  ATLANTA, GA 30341    US DEPT OF HEALTH & HUMAN SERVICES  ASPR/SNS  2945 Flowers Road  ATLANTA, GA 30341    8.  NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)  (x) 9A. AMENDMENT OF SOLICITATION NO.  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.  Attn:  STEVE RAMBO  EMERGENT PRODUCT DEVELOPMENT GAITHE  300 PROFESSIONAL DR  GAITHERSBURG MD 208793419      9B. DATED (SEE ITEM 11)     x 10A. MODIFICATION OF CONTRACT/ORDER NO.   75A50119C00071   10B. DATED (SEE ITEM 13)  CODE    1365869 FACILITY CODE     08/30/2019  11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS   The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offers  is extended,  is not extended.  Offers  must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items  8 and 15, and returning _________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or   (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO  BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR  OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each  letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA (If required)      See Schedule  13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.   IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.  CHECK ONE  A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT  ORDER NO. IN ITEM 10A.     B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office,  appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).    C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:        D. OTHER (Specify type of modification and authority)      E. IMPORTANT:  Contractor    is not,  is required to sign this document and return ________ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)  Tax ID Number: [**]  DUNS Number: [**]  ACAM2000, Smallpox (Vaccinia) Vaccine, Live (ACAM)    The purpose of this modification is to exchange CANs. Exchanging with DHA 75011997PR00065 and FBI 75012015PR0028 reimbursable funds.    No further changes.      Continued ...  Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print).    16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  NATASHA Y. ROWLAND  15B. CONTRACTOR/OFFEROR         15C. DATE  SIGNED  30 DEC 19   16B. UNITED STATES OF AMERICA  /s/ Natasha Rowland S   16C. DATE SIGNED  09/29/2021  

 

  (Signature of person authorized to sign)    (Signature of Contracting Officer)   STANDARD FORM 30 (Rev. 11/2016)  Previous edition unusable Prescribed by GSA   FAR (48 CFR) 53.243  

 

    CONTINUATION  SHEET  REFERENCE NO. OF DOCUMENT BEING CONTINUED  75A50119C00071/P00005  PAGE OF   2 3  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM No.  (A)  SUPPLIES/SERVICES  (B)  QUANTITY  (C)  UNIT  (D)  UNIT  PRICE  (E)  AMOUNT  (F)                                  5                            6            Period of Performance: 08/30/2019 to  08/29/2029  Change Item 5 to read as follows (amount  shown is the obligated amount):  Warm based manufacturing   delivery for  ACAM2000  Vaccine CAN   199SN21   [**]  Obligated Amount: [**]  Accounting Info:  2021.199SN21.26088 Appr. Yr.: 2021  CAN:   199SN21  Object Class: 26088  Funded: [**]  Change Item 6 to read as follows (amount  shown is the obligated amount):  Warm based manufacturing   delivery for  ACAM2000  Vaccine  CAN   199SN20   [**]  Obligated Amount: $[**]  Accounting Info:  2021.199SN20.26088 Appr. Yr.: 2012 CAN:  199SN20  Object Class: 26088  Continued ...                                                       [**]                          [**]    NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFR) 53.110   

 

    CONTINUATION  SHEET  REFERENCE NO. OF DOCUMENT BEING CONTINUED  75A50119C00071/P00005  PAGE OF   3 3  NAME OF OFFEROR OR CONTRACTOR  EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. 1365869  ITEM No.  (A)  SUPPLIES/SERVICES  (B)  QUANTITY  (C)  UNIT  (D)  UNIT  PRICE  (E)  AMOUNT  (F)              7                              8  Funded: $[**]    Add Item 7 as follows:  2004   Option 2   Year 3 ACAM 2000  Vaccine (FBI Reimursable)  Obligated Amount: $[**]       Project Data:  131036.1HA000SSNS01.26088-Strategic  National Stock.09/28/2021  Accounting Info:  2021.1990304.26088 Appr. Yr.: 2021    CAN: 1990304  Object Class: 26088  Funded: $[**]  Add Item 8 as follows:  2004   Option 2   Year 3 ACAM 2000  Vaccine (DHA Reimburs)  Obligated Amount: $[**]       Project Data:  131958.1.HA00OSSNS01.26088-Strategic  National Stock.09/28/2021  Accounting Info:  2021.1990475.26088  Apr. Yr: 2021  CAN:  1990475  Object Class: 26088  Funded: $[**]                                         [**]                              [**]    NSN 7540-01-152-8067 OPTIONAL FORM 336 (4-86)  Sponsored by GSA  FAR (48 CFR) 53.110

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}]]